Live from the NIH registry
Studies recruiting near McAllen right now
Top 25 of 133 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Valley Retina Institute — McAllen, Texas (1.8 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Knee Cartilage Defects
Phase 3
Interventional 300 participants sought
Futuro Clinical Trials — McAllen, Texas (1.8 mi)
· Sponsor: Medipost, Inc.
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 36 — Mission, Texas (4.9 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
DHR Health Gastroenterology - Edinburg — Edinburg, Texas (7.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — McAllen, Texas (1.8 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
Gamma Medical Research — McAllen, Texas (1.8 mi)
· Sponsor: R1 Therapeutics
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Valley Retina Institute, PA — McAllen, Texas (1.8 mi)
· Sponsor: Boehringer Ingelheim
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 162 — McAllen, Texas (1.8 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Pneumococcal Immunization, Healthy Volunteers
Phase 3
Interventional 2,195 participants sought
PAS Research - Children's Care Clinic- Site Number : 8400035 — Edinburg, Texas (7.4 mi)
· Sponsor: Sanofi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Texas Valley Clinical Research - Mission, TX — Mission, Texas (4.9 mi)
· Sponsor: Sparrow Pharmaceuticals
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Turner Syndrome, Short Stature Homeobox Gene Mutation
Phase 3
Interventional 186 participants sought
Ascendis Pharma Investigational Site — Edinburg, Texas (7.4 mi)
· Sponsor: Ascendis Pharma A/S
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Overweight, Obesity
Phase 3
Interventional 460 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Novo Nordisk A/S
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Phase 3
Interventional 660 participants sought
USOR - Texas Oncology — McAllen, Texas (1.8 mi)
· Sponsor: Genmab
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — McAllen, Texas (1.8 mi)
· Sponsor: Akero Therapeutics, Inc
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7062 — Edinburg, Texas (7.4 mi)
· Sponsor: Galderma R&D
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
Diabetic Foot Ulcer
N/A
Interventional 450 participants sought
Futuro Clinical Trials, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Piomic Medical
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Texas Oncology- Central South — Weslaco, Texas (16.5 mi)
· Sponsor: Stemline Therapeutics, Inc.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 920 participants sought
Nova Oncology — McAllen, Texas (1.8 mi)
· Sponsor: Eli Lilly and Company
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Irritable Bowel Syndrome, Constipation
Phase 2
Interventional 342 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Eli Lilly and Company
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Cushing Syndrome
Phase 2
Interventional 12 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: RECORDATI GROUP
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Phase 2
Interventional 240 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Eli Lilly and Company
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
COVID-19
Phase 3
Interventional 160 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Edinburg, Texas (7.4 mi)
· Sponsor: TG Therapeutics, Inc.
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 245 participants sought
Research Site — Edinburg, Texas (7.4 mi)
· Sponsor: AstraZeneca
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
Diabetic Foot Ulcer, Wagner Grade 1 - 2
Phase 1, Phase 2
Interventional 15 participants sought
Futuro Clinical Trials — McAllen, Texas (1.8 mi)
· Sponsor: Eluciderm Inc